The Potential of Live, Attenuated Influenza Vaccine for the Prevention of Influenza in Children

Affiliations

Editorial

Robert B Belshe. Clin Infect Dis. 2019.

. 2019 Aug 16;69(5):795-796.

doi: 10.1093/cid/ciy1007.

¹ Division of Infectious Diseases, Center for Vaccine Development, Saint Louis University School of Medicine, St Louis, Missouri.

No abstract available

Keywords: LAIV; influenza vaccine for children; vaccine efficacy.

Comment on

The Effect of Preexisting Immunity on Virus Detection and Immune Responses in a Phase II, Randomized Trial of a Russian-Backbone, Live, Attenuated Influenza Vaccine in Bangladeshi Children.
Brickley EB, Wright PF, Khalenkov A, Neuzil KM, Ortiz JR, Rudenko L, Levine MZ, Katz JM, Brooks WA. Brickley EB, et al. Clin Infect Dis. 2019 Aug 16;69(5):786-794. doi: 10.1093/cid/ciy1004. Clin Infect Dis. 2019. PMID: 30481269 Free PMC article. Clinical Trial.
Immunogenicity and Viral Shedding of Russian-Backbone, Seasonal, Trivalent, Live, Attenuated Influenza Vaccine in a Phase II, Randomized, Placebo-Controlled Trial Among Preschool-Aged Children in Urban Bangladesh.
Lewis KDC, Ortiz JR, Rahman MZ, Levine MZ, Rudenko L, Wright PF, Katz JM, Dally L, Rahman M, Isakova-Sivak I, Ilyushina NA, Matyushenko V, Fry AM, Lindstrom SE, Bresee JS, Brooks WA, Neuzil KM. Lewis KDC, et al. Clin Infect Dis. 2019 Aug 16;69(5):777-785. doi: 10.1093/cid/ciy1003. Clin Infect Dis. 2019. PMID: 30481272 Free PMC article. Clinical Trial.